MedPath

Effect of Bilinoeid drop on neonatal jaundice

Phase 2
Conditions
eonatal jaundice.
Neonatal jaundice, unspecified
P59.9
Registration Number
IRCT20160531028188N4
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

All infants who present with jaundice with weight between 2500 -4000 gr

Exclusion Criteria

Blood group or Rh incompatibility
Fauvism
immaturity
need for blood transfusions
hemolysis
infection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eonatal total bilirubin. Timepoint: every 24 hour til 5 days. Method of measurement: lab test.
Secondary Outcome Measures
NameTimeMethod
ength of hospitalization days. Timepoint: At the time of discharge. Method of measurement: From the time of admission to discharge.;The incidence of complications arising from the use of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;Evaluation of side effects in case of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;Frequency of defecation. Timepoint: every 24 hour til 5 days. Method of measurement: observation.
© Copyright 2025. All Rights Reserved by MedPath